Cellumed Co.,Ltd. (KOSDAQ:049180)

Cellumed Statistics

Total Valuation

Cellumed has a market cap or net worth of KRW 39.07 billion. The enterprise value is 45.95 billion.

Market Cap	39.07B
Enterprise Value	45.95B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Cellumed has 54.95 million shares outstanding. The number of shares has increased by 16.33% in one year.

Current Share Class	54.95M
Shares Outstanding	54.95M
Shares Change (YoY)	+16.33%
Shares Change (QoQ)	+5.78%
Owned by Insiders (%)	0.55%
Owned by Institutions (%)	2.29%
Float	42.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.27
PB Ratio	4.61
P/TBV Ratio	4.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.47
EV / Sales	0.32
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.38

Financial Position

The company has a current ratio of 0.92, with a Debt / Equity ratio of 1.59.

Current Ratio	0.92
Quick Ratio	0.40
Debt / Equity	1.59
Debt / EBITDA	n/a
Debt / FCF	-1.57
Interest Coverage	-13.33

Financial Efficiency

Return on equity (ROE) is -159.78% and return on invested capital (ROIC) is -24.49%.

Return on Equity (ROE)	-159.78%
Return on Assets (ROA)	-9.93%
Return on Invested Capital (ROIC)	-24.49%
Return on Capital Employed (ROCE)	-113.80%
Revenue Per Employee	1.61B
Profits Per Employee	-346.75M
Employee Count	90
Asset Turnover	1.88
Inventory Turnover	20.62

Taxes

Income Tax	-241.71M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.02% in the last 52 weeks. The beta is 1.18, so Cellumed's price volatility has been higher than the market average.

Beta (5Y)	1.18
52-Week Price Change	-81.02%
50-Day Moving Average	738.78
200-Day Moving Average	1,249.67
Relative Strength Index (RSI)	49.17
Average Volume (20 Days)	1,391,254

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cellumed had revenue of KRW 144.54 billion and -31.21 billion in losses. Loss per share was -599.72.

Revenue	144.54B
Gross Profit	4.04B
Operating Income	-12.21B
Pretax Income	-31.61B
Net Income	-31.21B
EBITDA	-11.28B
EBIT	-12.21B
Loss Per Share	-599.72

Balance Sheet

The company has 6.73 billion in cash and 13.43 billion in debt, giving a net cash position of -6.70 billion or -122.00 per share.

Cash & Cash Equivalents	6.73B
Total Debt	13.43B
Net Cash	-6.70B
Net Cash Per Share	-122.00
Equity (Book Value)	8.47B
Book Value Per Share	150.91
Working Capital	-5.39B

Cash Flow

In the last 12 months, operating cash flow was -7.27 billion and capital expenditures -1.27 billion, giving a free cash flow of -8.53 billion.

Operating Cash Flow	-7.27B
Capital Expenditures	-1.27B
Free Cash Flow	-8.53B
FCF Per Share	-155.33

Margins

Gross margin is 2.80%, with operating and profit margins of -8.45% and -21.59%.

Gross Margin	2.80%
Operating Margin	-8.45%
Pretax Margin	-21.87%
Profit Margin	-21.59%
EBITDA Margin	-7.81%
EBIT Margin	-8.45%
FCF Margin	n/a

Dividends & Yields

Cellumed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.33%
Shareholder Yield	n/a
Earnings Yield	-79.88%
FCF Yield	-21.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 28, 2017. It was a reverse split with a ratio of 0.1.

Last Split Date	Apr 28, 2017
Split Type	Reverse
Split Ratio	0.1

Scores

Cellumed has an Altman Z-Score of -0.54 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.54
Piotroski F-Score	2